Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes

This publication has 16 references indexed in Scilit:

• Improved detection ofCFTR mutations in Southern California Hispanic CF patients
  Human Mutation, 2001
• Laboratory standards and guidelines for population-based cystic fibrosis carrier screening
  Genetics in Medicine, 2001
• Protracted neonatal hypertrypsinogenaemia, normal sweat chloride, and cystic fibrosis
  Archives of Disease in Childhood, 2000
• Newborn Screening for Cystic Fibrosis in Wisconsin: Comparison of Biochemical and Molecular Methods
  Pediatrics, 1997
• Sweat testing for the diagnosis of cystic fibrosis: Practical considerations
  The Journal of Pediatrics, 1996
• Neonatal screening for cystic fibrosis: A comparison of two strategies for case detection in 1.2 million babies
  The Journal of Pediatrics, 1995
• Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis
  The Journal of Pediatrics, 1995
• The impact of newborn screening on cystic fibrosis testing in Victoria, Australia.
  Journal of Medical Genetics, 1995
• DRIED-BLOOD SPOT SCREENING FOR CYSTIC FIBROSIS IN THE NEWBORN
  The Lancet, 1979
• The Decline of the Sweat Test
  Clinical Pediatrics, 1973